172 related articles for article (PubMed ID: 32805081)
21. Follicular lymphoma in early stages: high risk of relapse and usefulness of the Follicular Lymphoma International Prognostic Index to predict the outcome of patients.
Plancarte F; López-Guillermo A; Arenillas L; Montoto S; Giné E; Muntañola A; Ferrer A; Villamor N; Bosch F; Colomo L; Balaguer O; Campo E; Montserrat E
Eur J Haematol; 2006 Jan; 76(1):58-63. PubMed ID: 16343272
[TBL] [Abstract][Full Text] [Related]
22. Progression of disease within 24 months of initial therapy (POD24) detected incidentally in imaging does not necessarily indicate worse outcome.
Bitansky G; Avigdor A; Vasilev E; Zlotnick M; Ribakovsky E; Benjamini O; Nagler A; Kedmi M
Leuk Lymphoma; 2020 Nov; 61(11):2645-2651. PubMed ID: 32643497
[TBL] [Abstract][Full Text] [Related]
23. Autologous transplantation improves survival rates for follicular lymphoma patients who relapse within two years of chemoimmunotherapy: a multi-center retrospective analysis of consecutively treated patients in the real world.
Manna M; Lee-Ying R; Davies G; Stewart C; Oh DH; Peters A; Stewart DA
Leuk Lymphoma; 2019 Jan; 60(1):133-141. PubMed ID: 29966465
[TBL] [Abstract][Full Text] [Related]
24. Anthracycline-containing regimens for treatment of follicular lymphoma in adults.
Itchaki G; Gafter-Gvili A; Lahav M; Vidal L; Raanani P; Shpilberg O; Paul M
Cochrane Database Syst Rev; 2013 Jul; (7):CD008909. PubMed ID: 23832787
[TBL] [Abstract][Full Text] [Related]
25. Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma.
Morschhauser F; Fowler NH; Feugier P; Bouabdallah R; Tilly H; Palomba ML; Fruchart C; Libby EN; Casasnovas RO; Flinn IW; Haioun C; Maisonneuve H; Ysebaert L; Bartlett NL; Bouabdallah K; Brice P; Ribrag V; Daguindau N; Le Gouill S; Pica GM; Martin Garcia-Sancho A; López-Guillermo A; Larouche JF; Ando K; Gomes da Silva M; André M; Zachée P; Sehn LH; Tobinai K; Cartron G; Liu D; Wang J; Xerri L; Salles GA;
N Engl J Med; 2018 Sep; 379(10):934-947. PubMed ID: 30184451
[TBL] [Abstract][Full Text] [Related]
26. Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.
Smith SM; Godfrey J; Ahn KW; DiGilio A; Ahmed S; Agrawal V; Bachanova V; Bacher U; Bashey A; Bolaños-Meade J; Cairo M; Chen A; Chhabra S; Copelan E; Dahi PB; Aljurf M; Farooq U; Ganguly S; Hertzberg M; Holmberg L; Inwards D; Kanate AS; Karmali R; Kenkre VP; Kharfan-Dabaja MA; Klein A; Lazarus HM; Mei M; Mussetti A; Nishihori T; Ramakrishnan Geethakumari P; Saad A; Savani BN; Schouten HC; Shah N; Urbano-Ispizua A; Vij R; Vose J; Sureda A; Hamadani M
Cancer; 2018 Jun; 124(12):2541-2551. PubMed ID: 29645093
[TBL] [Abstract][Full Text] [Related]
27. Early Progression of Follicular Lymphoma: Biology and Treatment.
Lipof JJ; Barr PM
Hematol Oncol Clin North Am; 2020 Aug; 34(4):757-769. PubMed ID: 32586579
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta-analysis.
Gao F; Zhang T; Liu H; Li W; Liu X; Qiu L; Li L; Zhou S; Qian Z; Dong S; Zhao S; Wang X; Zhang H
Ann Hematol; 2022 Nov; 101(11):2383-2392. PubMed ID: 36029326
[TBL] [Abstract][Full Text] [Related]
29. Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy.
Zucca E; Rondeau S; Vanazzi A; Østenstad B; Mey UJM; Rauch D; Wahlin BE; Hitz F; Hernberg M; Johansson AS; de Nully Brown P; Hagberg H; Ferreri AJM; Lohri A; Novak U; Zander T; Bersvendsen H; Bargetzi M; Mingrone W; Krasniqi F; Dirnhofer S; Hayoz S; Hawle H; Vilei SB; Ghielmini M; Kimby E;
Blood; 2019 Jul; 134(4):353-362. PubMed ID: 31101627
[TBL] [Abstract][Full Text] [Related]
30. A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy.
Bachy E; Maurer MJ; Habermann TM; Gelas-Dore B; Maucort-Boulch D; Estell JA; Van den Neste E; Bouabdallah R; Gyan E; Feldman AL; Bargay J; Delmer A; Slager SL; Gomes da Silva M; Fitoussi O; Belada D; Maisonneuve H; Intragumtornchai T; Ansell SM; Lamy T; Dartigues P; Link BK; Seymour JF; Cerhan JR; Salles G
Blood; 2018 Jul; 132(1):49-58. PubMed ID: 29666118
[TBL] [Abstract][Full Text] [Related]
31. Salvage Treatment and Survival for Relapsed Follicular Lymphoma Following Primary Radiation Therapy: A Collaborative Study on Behalf of ILROG.
Binkley MS; Brady JL; Hajj C; Chelius M; Chau K; Balogh A; Levis M; Filippi AR; Jones M; Ahmed S; MacManus M; Wirth A; Oguchi M; Vistisen AK; Andraos TY; Ng AK; Aleman BMP; Choi SH; Kirova YM; Hardy S; Reinartz G; Eich HT; Bratman SV; Constine LS; Suh CO; Dabaja B; El-Galaly TC; Hodgson DC; Ricardi U; Yahalom J; Mikhaeel NG; Hoppe RT
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):522-529. PubMed ID: 30858143
[TBL] [Abstract][Full Text] [Related]
32. Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy.
Murakami S; Kato H; Higuchi Y; Yamamoto K; Yamamoto H; Saito T; Taji H; Yatabe Y; Nakamura S; Kinoshita T
Ann Hematol; 2016 Aug; 95(8):1259-69. PubMed ID: 27220639
[TBL] [Abstract][Full Text] [Related]
33. Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population.
Magnano L; Alonso-Alvarez S; Alcoceba M; Rivas-Delgado A; Muntañola A; Nadeu F; Setoain X; Rodríguez S; Andrade-Campos M; Espinosa-Lara N; Rodríguez G; Sancho JM; Moreno M; Mercadal S; Carro I; Salar A; Garcia-Pallarols F; Arranz R; Cannata J; Terol MJ; Teruel AI; Jiménez-Ubieto A; Rodriguez A; González de Villambrosía S; Bello JL; López L; Novelli S; de Cabo E; Infante ME; Pardal E; Monsalvo S; González M; Martín A; Caballero MD; López-Guillermo A;
Br J Haematol; 2019 May; 185(3):480-491. PubMed ID: 30793290
[TBL] [Abstract][Full Text] [Related]
34. The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials.
Lansigan F; Barak I; Pitcher B; Jung SH; Cheson BD; Czuczman M; Martin P; Hsi E; Schöder H; Smith S; Bartlett NL; Leonard JP; Blum KA
Cancer Med; 2019 Jan; 8(1):165-173. PubMed ID: 30575311
[TBL] [Abstract][Full Text] [Related]
35. Early Progressing Follicular Lymphoma.
Wallace D; Casulo C
Curr Oncol Rep; 2021 Nov; 23(12):149. PubMed ID: 34797453
[TBL] [Abstract][Full Text] [Related]
36. The prognostic index PRIMA-PI combined with Ki67 as a better predictor of progression of disease within 24 months in follicular lymphoma.
Hu J; Gao F; Zhao J; Song W; Wang Y; Zheng Y; Wang L; Han W; Ma L; Wang J; Bai M; Guan T; Xi Y; Zhang H; Qiu L; Su L
Front Oncol; 2023; 13():1090610. PubMed ID: 37427106
[TBL] [Abstract][Full Text] [Related]
37. Response duration and survival shorten after each relapse in patients with follicular lymphoma treated in the rituximab era.
Rivas-Delgado A; Magnano L; Moreno-Velázquez M; García O; Nadeu F; Mozas P; Dlouhy I; Baumann T; Rovira J; González-Farre B; Martínez A; Balague O; Delgado J; Villamor N; Giné E; Campo E; Sancho-Cia JM; López-Guillermo A
Br J Haematol; 2019 Mar; 184(5):753-759. PubMed ID: 30515755
[TBL] [Abstract][Full Text] [Related]
38. Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma.
Gao F; Liu H; Meng X; Liu J; Wang J; Yu J; Liu X; Liu X; Li L; Qiu L; Qian Z; Zhou S; Gong W; Meng B; Ren X; Golchehre Z; Chavoshzadeh Z; He J; Zhang H; Wang X
Br J Haematol; 2023 Sep; 202(6):1151-1164. PubMed ID: 37455019
[TBL] [Abstract][Full Text] [Related]
39. The simplified follicular lymphoma PRIMA-prognostic index is useful in patients with first-line chemo-free rituximab-based therapy.
Kimby E; Lockmer S; Holte H; Hagberg H; Wahlin BE; Brown P; Østenstad B
Br J Haematol; 2020 Dec; 191(5):738-747. PubMed ID: 32410260
[TBL] [Abstract][Full Text] [Related]
40. Female patients with follicular lymphoma have a better prognosis if primary remission lasts over 24 months.
Rajamäki A; Sunela K; Prusila REI; Kuusisto MEL; Mercadal S; Selander T; Kuitunen H; Pollari M; Jantunen E; Nystrand I; Sancho JM; Sorigue M; Kuittinen O
Leuk Lymphoma; 2021 Jul; 62(7):1639-1647. PubMed ID: 33546574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]